Detail akcie Optigenex Inc, Ordinary, OTC Markets Group Inc - No Information online

Business Summary: Optigenex Inc. is an applied sciences company. The Company is focused on providing solutions for healthy age management. The Company is a provider of dietary supplements, skin care products and bulk ingredients. The Company formulates, licenses and markets its own natural cellular deoxyribonucleic acid (DNA) care ingredient known as ac-11. Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The Company’s technology helps the body’s natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation, and maintains telomere length and integrity during the process of cellular mitosis.
Financial Summary: BRIEF: For the six months ended 30 June 2010, Optigenex Inc revenues totaled $233K. Net loss totaled to $521K.